🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
Status
Completed
Location
TESARO Inc
Start Date
2012-02
Trial ID
NCT01499849
Treatments Being Tested
This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
Status
Completed
Location
TESARO Inc
Start Date
2012-02
Trial ID
NCT01500213
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of singl...
Status
Completed
Location
Parexel
Start Date
2015-01
Trial ID
NCT02382666
Treatments Being Tested
This is an open-label, randomized, single-dose, single-center, parallel-gro...
Status
Completed
Location
Parexel
Start Date
2014-09
Trial ID
NCT02285647
Treatments Being Tested
The objective of this Open Label Study is to evaluate effects of Rolapitant...
Status
Completed
Location
Parexel Early Phase Unit
Start Date
2015-05
Trial ID
NCT02434861
Treatments Being Tested
This study aims to evaluate the efficacy and safety of a combination regime...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-30
Trial ID
NCT07442890
Treatments Being Tested
Phase II study of Rolapitant plus Olanzapine, Palonosetron, and Dexamethaso...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-05
Trial ID
NCT03960151
Treatments Being Tested
This randomized phase II trial studies how well rolapitant hydrochloride wo...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2016-10-12
Trial ID
NCT02732015